Identifying Rare Dermatologic Disorders in the Critical Care Setting : Episode 9

Video

May 26, 2023

Use of Biologics in Rare Dermatologic Disorders

Author(s):

Raj Chovatiya, MD, PhD,Boni Elewski, MD

Experts discuss the use of biologics in the treatment of rare dermatologic disorders.

EP: 1.Prevalence of Rare Dermatological Disorders

EP: 2.Symptoms of Rare Dermatological Disorders

EP: 3.Pathophysiology of GPP, PPP, and SJS

EP: 4.GPP, PPP and SJS: Typical Patient Journey

EP: 5.Diagnosis of Rare Dermatological Disorders

EP: 6.Differential Diagnosis of Rare Skin Conditions

EP: 7.Challenges in Managing Rare Skin Conditions

EP: 8.Initial Management Of Patients With Rare Dermatological Disorders

EP: 9.Use of Biologics in Rare Dermatologic Disorders

EP: 10.Spesolimab for Treatment of GPP

EP: 11.Future Treatment Outlook for Rare Dermatological Disorders

EP: 12.Improving Recognition and Referral of Rare Conditions in Rare Setting

EP: 13.Patient Subgroups and Educational Opportunities in Rare Dermatological Disorders

EP: 14.Recommendations for Management of Rare Dermatological Disorders in Critical Care Setting

Related Videos

Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa

Omega-3 Supplements for Rosacea and Other Tips for Dermatologists, with Andrea Murina, MD

Methods to Manage Psoriasis Using Oral Therapies, with Andrea Murina, MD

2 Additional Clinical Pearls for Dermatologists, with Eingun James Song, MD

2 Helpful Clinical Tips for Dermatologists, with Eingun James Song, MD

What Are Some Other Methods To Manage Skin Cancer Outside of Biopsies?

New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD

Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action

Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.